Invivyd (IVVD) Earnings Date & Reports

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVVD is expected to report earnings to fall 88.87% to -1 cents per share on May 08

Q1'25

Est.

$-0.02

Q4'24

Beat

by $0.07

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.03

Q1'24

Beat

by $0.05

The last earnings report on March 20 showed earnings per share of -15 cents, beating the estimate of -21 cents. With 1.71M shares outstanding, the current market capitalization sits at 69.47M.

View a ticker or compare two or three

Compare

IVVD